{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:59:53Z","timestamp":1780621193804,"version":"3.54.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"DOI":"10.1186\/s41181-026-00444-0","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:53:12Z","timestamp":1776480792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [212Pb]Pb-FAPI-46"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9548-8056","authenticated-orcid":false,"given":"Sandra K.","family":"Kristiansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8157-6128","authenticated-orcid":false,"given":"Nurtene","family":"Dernjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-3733","authenticated-orcid":false,"given":"\u00d8yvind S.","family":"Bruland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6995-131X","authenticated-orcid":false,"given":"Nina Frederike J.","family":"Edin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-0062","authenticated-orcid":false,"given":"Asta","family":"Juzeniene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"7","key":"444_CR1","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1021\/mp500002y","volume":"11","author":"TM Achilli","year":"2014","unstructured":"Achilli TM, McCalla S, Meyer J, Tripathi A, Morgan JR. Multilayer spheroids to quantify drug uptake and diffusion in 3D. Mol Pharm. 2014;11(7):2071\u201381. https:\/\/doi.org\/10.1021\/mp500002y.","journal-title":"Mol Pharm"},{"issue":"4","key":"444_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1053\/j.semnuclmed.2024.02.007","volume":"54","author":"H Ahmadzadehfar","year":"2024","unstructured":"Ahmadzadehfar H, Seifert R, Afshar-Oromieh A, Kratochwil C, Rahbar K. Prostate cancer theranostics with 177Lu-PSMA. Semin Nucl Med. 2024;54(4):581\u201390. https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.02.007.","journal-title":"Semin Nucl Med"},{"issue":"9","key":"444_CR3","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1007\/s00259-025-07123-3","volume":"52","author":"L Bokhout","year":"2025","unstructured":"Bokhout L, Campeiro JD, Dalm SU. Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics. Eur J Nucl Med Mol Imaging. 2025;52(9):3291\u2013311. https:\/\/doi.org\/10.1007\/s00259-025-07123-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"444_CR4","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/1878-0261.13653","volume":"19","author":"R Booijink","year":"2025","unstructured":"Booijink R, Terstappen L, Dathathri E, Isebia K, Kraan J, Martens J, et al. Identification of functional and diverse circulating cancer-associated fibroblasts in metastatic castration-naive prostate cancer patients. Mol Oncol. 2025;19(7):2074\u201391. https:\/\/doi.org\/10.1002\/1878-0261.13653.","journal-title":"Mol Oncol"},{"issue":"supplement 2","key":"444_CR5","first-page":"241158","volume":"65","author":"B Cagle","year":"2024","unstructured":"Cagle B, Baumhover N, Vance I, Liu D, Rodman S, Kalen A, et al. De novo discovery and preclinical evaluation of cyclic radiopeptide [203\/212Pb]Pb-PSV-359 targeting human fibroblast activation protein for alpha-particle radiotherapy in cancers. J Nucl Med. 2024;65(supplement 2):241158.","journal-title":"J Nucl Med"},{"key":"444_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-82340-4_1","volume":"95","author":"J Carlsson","year":"1984","unstructured":"Carlsson J, Yuhas JM. Liquid-overlay culture of cellular spheroids. Recent Results Cancer Res. 1984;95:1\u201323. https:\/\/doi.org\/10.1007\/978-3-642-82340-4_1.","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"444_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1967\/s002449912723","volume":"27","author":"H Dadgar","year":"2024","unstructured":"Dadgar H, Norouzbeigi N, Assadi M, Al-Balooshi B, Al-Ibraheem A, Esmail AA, et al. Initial clinical experience using 68Ga-FAPI-46 PET\/CT for detecting various cancer types. Hell J Nucl Med. 2024;27(2):105\u201320. https:\/\/doi.org\/10.1967\/s002449912723.","journal-title":"Hell J Nucl Med"},{"issue":"11","key":"444_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/17474124.2019.1685381","volume":"13","author":"S Das","year":"2019","unstructured":"Das S, Al-Toubah T, El-Haddad G, Strosberg J. 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2019;13(11):1023\u201331. https:\/\/doi.org\/10.1080\/17474124.2019.1685381.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"444_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12964-021-00711-4","volume":"19","author":"JD Domogauer","year":"2021","unstructured":"Domogauer JD, de Toledo SM, Howell RW, Azzam EI. Acquired radioresistance in cancer associated fibroblasts is concomitant with enhanced antioxidant potential and DNA repair capacity. Cell Commun Signal. 2021;19(1):30. https:\/\/doi.org\/10.1186\/s12964-021-00711-4.","journal-title":"Cell Commun Signal"},{"key":"444_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091458","author":"T Eder","year":"2016","unstructured":"Eder T, Weber A, Neuwirt H, Gr\u00fcnbacher G, Ploner C, Klocker H, et al. Cancer-associated fibroblasts modify the response of prostate cancer cells to androgen and anti-androgens in three-dimensional spheroid culture. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17091458.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"444_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"444_CR12","doi-asserted-by":"publisher","first-page":"23526","DOI":"10.1038\/s41598-024-73680-6","volume":"14","author":"I Fl\u00f6rkemeier","year":"2024","unstructured":"Fl\u00f6rkemeier I, Antons LK, Weimer JP, Hedemann N, Rogmans C, Kr\u00fcger S, et al. Multicellular ovarian cancer spheroids: novel 3D model to mimic tumour complexity. Sci Rep. 2024;14(1):23526. https:\/\/doi.org\/10.1038\/s41598-024-73680-6.","journal-title":"Sci Rep"},{"issue":"3","key":"444_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1084\/jem.20180765","volume":"216","author":"Q Gao","year":"2019","unstructured":"Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, et al. Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216(3):688\u2013703. https:\/\/doi.org\/10.1084\/jem.20180765.","journal-title":"J Exp Med"},{"issue":"18","key":"444_CR14","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A. 1990;87(18):7235\u20139. https:\/\/doi.org\/10.1073\/pnas.87.18.7235.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"444_CR15","doi-asserted-by":"publisher","first-page":"17038","DOI":"10.1038\/cddiscovery.2017.38","volume":"3","author":"G Granato","year":"2017","unstructured":"Granato G, Ruocco MR, Iaccarino A, Masone S, Cal\u00ec G, Avagliano A, et al. Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation. Cell Death Discov. 2017;3:17038. https:\/\/doi.org\/10.1038\/cddiscovery.2017.38.","journal-title":"Cell Death Discov"},{"issue":"1","key":"444_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41420-023-01306-3","volume":"9","author":"Z Guo","year":"2023","unstructured":"Guo Z, Zhang H, Fu Y, Kuang J, Zhao B, Zhang L, et al. Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell Death Discov. 2023;9(1):6. https:\/\/doi.org\/10.1038\/s41420-023-01306-3.","journal-title":"Cell Death Discov"},{"issue":"3","key":"444_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2967\/jnumed.123.266652","volume":"65","author":"N Hirmas","year":"2024","unstructured":"Hirmas N, Hamacher R, Sraieb M, Kessler L, Pabst KM, Barbato F, et al. Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies. J Nucl Med. 2024;65(3):372\u20138. https:\/\/doi.org\/10.2967\/jnumed.123.266652.","journal-title":"J Nucl Med"},{"issue":"1","key":"444_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s41181-025-00356-5","volume":"10","author":"A Homedan","year":"2025","unstructured":"Homedan A, Pandya DN, Schnicker NJ, Wadas TJ. Protein-based radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress. EJNMMI Radiopharm Chem. 2025;10(1):32. https:\/\/doi.org\/10.1186\/s41181-025-00356-5.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"444_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-021-01878-x","volume":"40","author":"W Huang","year":"2021","unstructured":"Huang W, Zhang L, Yang M, Wu X, Wang X, Huang W, et al. Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-\u03baB pathway. J Exp Clin Cancer Res. 2021;40(1):87. https:\/\/doi.org\/10.1186\/s13046-021-01878-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"444_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13643-025-02929-6","volume":"14","author":"M Janani","year":"2025","unstructured":"Janani M, Poorkhani A, Sharifiandavaei M, Akbari Z, Pourkhalili K, Golfiroozi S, et al. Predicting fibroblast activation protein overexpression in the overall survival rate of cancer patients: a systematic review and meta-analysis. Syst Rev. 2025;14(1):178. https:\/\/doi.org\/10.1186\/s13643-025-02929-6.","journal-title":"Syst Rev"},{"issue":"11","key":"444_CR23","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/adma.201404715","volume":"27","author":"T Ji","year":"2015","unstructured":"Ji T, Ding Y, Zhao Y, Wang J, Qin H, Liu X, et al. Peptide assembly integration of fibroblast-targeting and cell-penetration features for enhanced antitumor drug delivery. Adv Mater. 2015;27(11):1865\u201373. https:\/\/doi.org\/10.1002\/adma.201404715.","journal-title":"Adv Mater"},{"issue":"3","key":"444_CR24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/anie.201506262","volume":"55","author":"T Ji","year":"2016","unstructured":"Ji T, Zhao Y, Ding Y, Wang J, Zhao R, Lang J, et al. Transformable peptide nanocarriers for expeditious drug release and effective cancer therapy via cancer-associated fibroblast activation. Angew Chem Int Ed. 2016;55(3):1050\u20135. https:\/\/doi.org\/10.1002\/anie.201506262.","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"444_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18(1):36. https:\/\/doi.org\/10.1186\/s13045-025-01688-0.","journal-title":"J Hematol Oncol"},{"issue":"52","key":"444_CR26","doi-asserted-by":"publisher","first-page":"51349","DOI":"10.1021\/acsomega.4c08214","volume":"9","author":"B Judmann","year":"2024","unstructured":"Judmann B, Keller F, W\u00e4ngler B, Schirrmacher R, Rudolf R, W\u00e4ngler C. Are 3D tumor cell spheroids a utile system for the in vitro evaluation of diagnostic radiotracers? ACS Omega. 2024;9(52):51349\u201362. https:\/\/doi.org\/10.1021\/acsomega.4c08214.","journal-title":"ACS Omega"},{"issue":"1","key":"444_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00259-021-05423-y","volume":"49","author":"C Kesch","year":"2021","unstructured":"Kesch C, Yirga L, Dendl K, Handke A, Darr C, Krafft U, et al. High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics. Eur J Nucl Med Mol Imaging. 2021;49(1):385\u20139. https:\/\/doi.org\/10.1007\/s00259-021-05423-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"444_CR28","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00259-019-04623-x","volume":"47","author":"F Khreish","year":"2020","unstructured":"Khreish F, Rosar F, Kratochwil C, Giesel FL, Haberkorn U, Ezziddin S. Positive FAPI-PET\/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative\/FDG-positive disease. Eur J Nucl Med Mol Imaging. 2020;47(8):2040\u20131. https:\/\/doi.org\/10.1007\/s00259-019-04623-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"444_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010189","author":"KV Kokov","year":"2022","unstructured":"Kokov KV, Egorova BV, German MN, Klabukov ID, Krasheninnikov ME, Larkin-Kondrov AA, et al. 212Pb: Production Approaches and Targeted Therapy Applications. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14010189.","journal-title":"Pharmaceutics"},{"issue":"12","key":"444_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.neo.2020.10.001","volume":"22","author":"B Krishnamachary","year":"2020","unstructured":"Krishnamachary B, Mironchik Y, Jacob D, Goggins E, Kakkad S, Ofori F, et al. Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment. Neoplasia. 2020;22(12):679\u201388. https:\/\/doi.org\/10.1016\/j.neo.2020.10.001.","journal-title":"Neoplasia"},{"key":"444_CR31","doi-asserted-by":"publisher","unstructured":"Kristiansen SK, Shubin K, Zubrien\u0117 A, Matulis D, Dernjani N, Juzenas P, et al. Radiobiological investigations of a [212Pb]Pb-carbonic anhydrase IX-targeting small-molecule ligand in renal cell carcinoma and colorectal cancer models. Int J Radiat Biol. 2026;1\u201311. https:\/\/doi.org\/10.1080\/09553002.2025.2595630.","DOI":"10.1080\/09553002.2025.2595630"},{"issue":"3","key":"444_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40291-024-00702-4","volume":"28","author":"IO Lawal","year":"2024","unstructured":"Lawal IO, Abubakar SO, Ndlovu H, Mokoala KMG, More SS, Sathekge MM. Advances in Radioligand Theranostics in Oncology. Mol Diagn Ther. 2024;28(3):265\u201389. https:\/\/doi.org\/10.1007\/s40291-024-00702-4.","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"444_CR33","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.7150\/thno.108676","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Guan L, Zhang X, Li J, Wang X, Li W, et al. Dual targeting PET tracer [68Ga]Ga-PSFA-01 in patients with prostate cancers: A pilot exploratory study. Theranostics. 2025;15(9):4124\u201334. https:\/\/doi.org\/10.7150\/thno.108676.","journal-title":"Theranostics"},{"key":"444_CR34","doi-asserted-by":"publisher","first-page":"158308","DOI":"10.1016\/j.cej.2024.158308","volume":"503","author":"J Li","year":"2025","unstructured":"Li J, Lei T, Ouyang W, Ye Z, Li L, Li G, et al. Reshape tumor microenvironment by modulating CXCR4 with FAP-targeted diselenide-organosilica delivery system for prostate cancer immunotherapy. Chem Eng J. 2025;503:158308. https:\/\/doi.org\/10.1016\/j.cej.2024.158308.","journal-title":"Chem Eng J"},{"issue":"1","key":"444_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2967\/jnumed.122.264009","volume":"64","author":"RG Li","year":"2023","unstructured":"Li RG, Stenberg VY, Larsen RH. An experimental generator for production of high-purity 212Pb for use in radiopharmaceuticals. J Nucl Med. 2023;64(1):173. https:\/\/doi.org\/10.2967\/jnumed.122.264009.","journal-title":"J Nucl Med"},{"key":"444_CR36","doi-asserted-by":"publisher","unstructured":"Li L, Wei JR, Dong J, Lin QG, Tang H, Jia YX, et al. Laminin gamma2-mediating T cell exclusion attenuates response to anti-PD-1 therapy. Sci Adv. 2021;7(6). https:\/\/doi.org\/10.1126\/sciadv.abc8346.","DOI":"10.1126\/sciadv.abc8346"},{"issue":"1","key":"444_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s41181-025-00382-3","volume":"10","author":"K Lindland","year":"2025","unstructured":"Lindland K, Juzeniene A. Cytotoxicity of 212Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models. EJNMMI Radiopharm Chem. 2025;10(1):58. https:\/\/doi.org\/10.1186\/s41181-025-00382-3.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"444_CR38","doi-asserted-by":"publisher","first-page":"12575","DOI":"10.1038\/s41598-020-69424-x","volume":"10","author":"J Linxweiler","year":"2020","unstructured":"Linxweiler J, Hajili T, Korbel C, Berchem C, Zeuschner P, Muller A, et al. Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model. Sci Rep. 2020;10(1):12575. https:\/\/doi.org\/10.1038\/s41598-020-69424-x.","journal-title":"Sci Rep"},{"issue":"8","key":"444_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12032-025-02925-9","volume":"42","author":"R Liukaityte","year":"2025","unstructured":"Liukaityte R, Stenberg VY, Kleinauskas A, Juzenas P, Urbanucci A, Juzeniene A. Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models. Med Oncol. 2025;42(8):362. https:\/\/doi.org\/10.1007\/s12032-025-02925-9.","journal-title":"Med Oncol"},{"key":"444_CR40","doi-asserted-by":"publisher","unstructured":"Lohse I, Crossman C, Pereira K, Haller AC, Chung SSM, Pintilie M, et al. Co-Injection of patient-derived fibroblasts enhances tumor growth, stromal invasion, and epithelial-to- mesenchymal transition. J Cancer Res Ther. 2015;4(2). https:\/\/doi.org\/10.7243\/2049-7962-4-2.","DOI":"10.7243\/2049-7962-4-2"},{"issue":"1","key":"444_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/carcin\/bgn232","volume":"30","author":"S Madar","year":"2009","unstructured":"Madar S, Brosh R, Buganim Y, Ezra O, Goldstein I, Solomon H, et al. Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis. 2009;30(1):20\u20137. https:\/\/doi.org\/10.1093\/carcin\/bgn232.","journal-title":"Carcinogenesis"},{"issue":"5","key":"444_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15(5):307. https:\/\/doi.org\/10.1038\/s41419-024-06697-4.","journal-title":"Cell Death Dis"},{"issue":"6","key":"444_CR43","doi-asserted-by":"publisher","first-page":"e0127948","DOI":"10.1371\/journal.pone.0127948","volume":"10","author":"M Majety","year":"2015","unstructured":"Majety M, Pradel LP, Gies M, Ries CH. Fibroblasts Influence Survival and Therapeutic Response in a 3D Co-Culture Model. PLoS ONE. 2015;10(6):e0127948. https:\/\/doi.org\/10.1371\/journal.pone.0127948.","journal-title":"PLoS ONE"},{"key":"444_CR44","doi-asserted-by":"publisher","unstructured":"Martin M, Ballal S, Yadav MP, Bal C, Van Rymenant Y, De Loose J, et al. Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics. Cancers (Basel). 2023;15(6). https:\/\/doi.org\/10.3390\/cancers15061889.","DOI":"10.3390\/cancers15061889"},{"key":"444_CR45","unstructured":"Mei J. Effect of radiation and co-culture with fibroblasts on growth characteristics and invasiveness of 3D breast cancer models. Faculty of Biology: Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen;; 2022."},{"issue":"1","key":"444_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41389-022-00434-2","volume":"11","author":"AM Mello","year":"2022","unstructured":"Mello AM, Ngodup T, Lee Y, Donahue KL, Li J, Rao A, et al. Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer. Oncogenesis. 2022;11(1):56. https:\/\/doi.org\/10.1038\/s41389-022-00434-2.","journal-title":"Oncogenesis"},{"key":"444_CR47","doi-asserted-by":"publisher","unstructured":"Mirzadeh S, Kumar K, Gansow OA. The chemical fate of 212Bi-DOTA formed by \u03b2- decay of 212Pb(DOTA)2-***. Radiochim Acta. 1993;60(1):1\u201310. https:\/\/doi.org\/10.1524\/ract.1993.60.1.1.","DOI":"10.1524\/ract.1993.60.1.1"},{"key":"444_CR48","doi-asserted-by":"publisher","unstructured":"Mohmand-Borkowski A, Rozmyslowicz T. Immunohistochemical Localization of Fibroblast Activation Protein in Coronary Arteries with Different Forms of Atherosclerosis. Metabolites. 2024;14(11). https:\/\/doi.org\/10.3390\/metabo14110573.","DOI":"10.3390\/metabo14110573"},{"issue":"9","key":"444_CR49","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1111\/cas.70133","volume":"116","author":"Y Naito","year":"2025","unstructured":"Naito Y. How Do Cancer Cells Create Cancer-Associated Fibroblast Subtypes? Impacts of Extracellular Vesicles on Stromal Diversity. Cancer Sci. 2025;116(9):2347\u201361. https:\/\/doi.org\/10.1111\/cas.70133.","journal-title":"Cancer Sci"},{"key":"444_CR50","doi-asserted-by":"publisher","first-page":"109362","DOI":"10.1016\/j.apradiso.2020.109362","volume":"166","author":"E Napoli","year":"2020","unstructured":"Napoli E, Stenberg VY, Juzeniene A, Hjellum GE, Bruland \u00d8S, Larsen RH. Calibration of sodium iodide detectors and reentrant ionization chambers for 212Pb activity in different geometries by HPGe activity determined samples. Appl Radiat Isot. 2020;166:109362. https:\/\/doi.org\/10.1016\/j.apradiso.2020.109362.","journal-title":"Appl Radiat Isot"},{"key":"444_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","volume":"163","author":"S Nath","year":"2016","unstructured":"Nath S, Devi GR. Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacol Ther. 2016;163:94\u2013108. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.013.","journal-title":"Pharmacol Ther"},{"key":"444_CR52","doi-asserted-by":"publisher","first-page":"1133160","DOI":"10.3389\/fimmu.2023.1133160","volume":"14","author":"J Pan","year":"2023","unstructured":"Pan J, Ma Z, Liu B, Qian H, Shao X, Liu J, et al. Identification of cancer-associated fibroblasts subtypes in prostate cancer. Front Immunol. 2023;14:1133160. https:\/\/doi.org\/10.3389\/fimmu.2023.1133160.","journal-title":"Front Immunol"},{"issue":"2","key":"444_CR53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2015.10.021","volume":"370","author":"YJ Park","year":"2016","unstructured":"Park YJ, Kim EK, Bae JY, Moon S, Kim J. Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1. Cancer Lett. 2016;370(2):222\u201331. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.021.","journal-title":"Cancer Lett"},{"issue":"10","key":"444_CR54","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2967\/jnumed.120.251512","volume":"62","author":"S Park","year":"2021","unstructured":"Park S, Parihar AS, Bodei L, Hope TA, Mallak N, Millo C, et al. Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects. J Nucl Med. 2021;62(10):1323\u20139. https:\/\/doi.org\/10.2967\/jnumed.120.251512.","journal-title":"J Nucl Med"},{"key":"444_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.apradiso.2014.03.006","volume":"90","author":"SN Penfold","year":"2014","unstructured":"Penfold SN, Brown MP, Staudacher AH, Bezak E. Monte Carlo simulations of dose distributions with necrotic tumor targeted radioimmunotherapy. Appl Radiat Isot. 2014;90:40\u20135. https:\/\/doi.org\/10.1016\/j.apradiso.2014.03.006.","journal-title":"Appl Radiat Isot"},{"issue":"6","key":"444_CR56","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2967\/jnumed.116.186338","volume":"59","author":"S Poty","year":"2018","unstructured":"Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. \u03b1-Emitters for radiotherapy: from basic radiochemistry to clinical studies-part 1. J Nucl Med. 2018;59(6):878\u201384. https:\/\/doi.org\/10.2967\/jnumed.116.186338.","journal-title":"J Nucl Med"},{"issue":"1","key":"444_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s41181-024-00305-8","volume":"9","author":"M Pretze","year":"2024","unstructured":"Pretze M, Michler E, Kastner D, Kunkel F, Sagastume EA, Schultz MK, et al. Lead-it-EAZY! GMP-compliant production of [212Pb]Pb-PSC-PEG(2)-TOC. EJNMMI Radiopharm Chem. 2024;9(1):81. https:\/\/doi.org\/10.1186\/s41181-024-00305-8.","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"32","key":"444_CR58","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/sj.onc.1207730","volume":"23","author":"T Ramirez-Montagut","year":"2004","unstructured":"Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, et al. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene. 2004;23(32):5435\u201346. https:\/\/doi.org\/10.1038\/sj.onc.1207730.","journal-title":"Oncogene"},{"issue":"1","key":"444_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41420-025-02792-3","volume":"11","author":"F Rantanen","year":"2025","unstructured":"Rantanen F, Murumagi A, Arjama M, Valimaki K, Multamaki E, Mirtti T, et al. Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities. Cell Death Discov. 2025;11(1):507. https:\/\/doi.org\/10.1038\/s41420-025-02792-3.","journal-title":"Cell Death Discov"},{"issue":"9","key":"444_CR60","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.85.9.3110","volume":"85","author":"WJ Rettig","year":"1988","unstructured":"Rettig WJ, Garin-Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A. 1988;85(9):3110\u20134. https:\/\/doi.org\/10.1073\/pnas.85.9.3110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"444_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mrfmmm.2011.07.018","volume":"716","author":"B Schilling-T\u00f3th","year":"2011","unstructured":"Schilling-T\u00f3th B, S\u00e1ndor N, Kis E, Kadhim M, S\u00e1fr\u00e1ny G, Hegyesi H. Analysis of the common deletions in the mitochondrial DNA is a sensitive biomarker detecting direct and non-targeted cellular effects of low dose ionizing radiation. Mutat Res. 2011;716(1):33\u20139. https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.07.018.","journal-title":"Mutat Res"},{"issue":"Pt 3","key":"444_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","volume":"86","author":"E Schoutrop","year":"2022","unstructured":"Schoutrop E, Moyano-Galceran L, Lheureux S, Mattsson J, Lehti K, Dahlstrand H, et al. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Semin Cancer Biol. 2022;86(Pt 3):207\u201323. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.027.","journal-title":"Semin Cancer Biol"},{"key":"444_CR63","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2025.11.022","author":"SC Siegmund","year":"2025","unstructured":"Siegmund SC, Novruzov E, Mamlins E, Mori Y, Otto S, Canis M, et al. Current status of FAP therapy in solid tumors. Semin Nucl Med. 2025. https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.11.022.","journal-title":"Semin Nucl Med"},{"issue":"11","key":"444_CR64","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.18632\/aging.103261","volume":"12","author":"JD Solano-Iturri","year":"2020","unstructured":"Solano-Iturri JD, Beitia M, Errarte P, Calvete-Candenas J, Etxezarraga MC, Loizate A, et al. Altered expression of fibroblast activation protein-alpha (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases. Aging. 2020;12(11):10337\u201358. https:\/\/doi.org\/10.18632\/aging.103261.","journal-title":"Aging"},{"issue":"1","key":"444_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13062-025-00667-2","volume":"20","author":"X Song","year":"2025","unstructured":"Song X, Li T, Zhou W, Feng C, Zhou Z, Chen Y, et al. CAF-derived exosomal miR-196b-5p after androgen deprivation therapy promotes epithelial-mesenchymal transition in prostate cancer cells through HOXC8\/NF-\u03baB signaling pathway. Biol Direct. 2025;20(1):80. https:\/\/doi.org\/10.1186\/s13062-025-00667-2.","journal-title":"Biol Direct"},{"issue":"2","key":"444_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antib1020124","volume":"1","author":"H Song","year":"2012","unstructured":"Song H, Senthamizhchelvan S, Hobbs RF, Sgouros G. Alpha particle emitter radiolabeled antibody for metastatic cancer: what can we learn from heavy ion beam radiobiology? Antibodies. 2012;1(2):124\u201348. https:\/\/doi.org\/10.3390\/antib1020124.","journal-title":"Antibodies"},{"issue":"7","key":"444_CR67","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11626-999-0115-4","volume":"35","author":"RM Sramkoski","year":"1999","unstructured":"Sramkoski RM, Pretlow TG 2nd, Giaconia JM, Pretlow TP, Schwartz S, Sy MS, et al. A new human prostate carcinoma cell line, 22Rv1. Vitro Cell Dev Biol Anim. 1999;35(7):403\u20139. https:\/\/doi.org\/10.1007\/s11626-999-0115-4.","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"444_CR68","doi-asserted-by":"publisher","unstructured":"Staniszewska M, Fragoso Costa P, Eiber M, Klose JM, Wosniack J, Reis H, et al. Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. Int J Mol Sci. 2021;22(14). https:\/\/doi.org\/10.3390\/ijms22147431.","DOI":"10.3390\/ijms22147431"},{"issue":"12","key":"444_CR69","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/MNM.0000000000000199","volume":"35","author":"AH Staudacher","year":"2014","unstructured":"Staudacher AH, Bezak E, Borysenko A, Brown MP. Targeted \u03b1-therapy using 227Th-APOMAB and cross-fire antitumour effects: preliminary in-vivo evaluation. Nucl Med Commun. 2014;35(12):1284\u201390. https:\/\/doi.org\/10.1097\/MNM.0000000000000199.","journal-title":"Nucl Med Commun"},{"key":"444_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fmolb.2019.00070","volume":"6","author":"A Steer","year":"2019","unstructured":"Steer A, Cordes N, Jendrossek V, Klein D. Impact of Cancer-Associated Fibroblast on the Radiation-Response of Solid Xenograft Tumors. Front Mol Biosci. 2019;6:70. https:\/\/doi.org\/10.3389\/fmolb.2019.00070.","journal-title":"Front Mol Biosci"},{"key":"444_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-29785-7","author":"VY Stenberg","year":"2025","unstructured":"Stenberg VY, Liukaityte R, Kristiansen SK, Wangen-Riise R, Kleinauskas A, Dunne V, et al. Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-29785-7.","journal-title":"Sci Rep"},{"issue":"1","key":"444_CR72","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.clgc.2016.09.002","volume":"15","author":"JJ Tosoian","year":"2017","unstructured":"Tosoian JJ, Gorin MA, Rowe SP, Andreas D, Szabo Z, Pienta KJ, et al. Correlation of PSMA-Targeted 18F-DCFPyL PET\/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer. Clin Genitourin Cancer. 2017;15(1):e65\u20138. https:\/\/doi.org\/10.1016\/j.clgc.2016.09.002.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"444_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40658-022-00497-5","volume":"9","author":"J Tranel","year":"2022","unstructured":"Tranel J, Palm S, Graves SA, Feng FY, Hope TA. Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model. EJNMMI Phys. 2022;9(1):67. https:\/\/doi.org\/10.1186\/s40658-022-00497-5.","journal-title":"EJNMMI Phys"},{"issue":"1","key":"444_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13550-024-01191-6","volume":"14","author":"CD van der Heide","year":"2024","unstructured":"van der Heide CD, Campeiro JD, Ruigrok EAM, van den Brink L, Ponnala S, Hillier SM, et al. In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation. EJNMMI Res. 2024;14(1):125. https:\/\/doi.org\/10.1186\/s13550-024-01191-6.","journal-title":"EJNMMI Res"},{"issue":"13","key":"444_CR18","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1007\/s00259-022-05870-1","volume":"49","author":"CD van der Heide","year":"2022","unstructured":"van der Heide CD, Dalm SU. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine. Eur J Nucl Med Mol Imaging. 2022;49(13):4616\u201341. https:\/\/doi.org\/10.1007\/s00259-022-05870-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"444_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ebiom.2017.02.019","volume":"17","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gan G, Wang B, Wu J, Cao Y, Zhu D, et al. Cancer-associated fibroblasts promote irradiated cancer cell recovery through autophagy. eBioMedicine. 2017;17:45\u201356. https:\/\/doi.org\/10.1016\/j.ebiom.2017.02.019.","journal-title":"eBioMedicine"},{"key":"444_CR75","doi-asserted-by":"publisher","first-page":"108971","DOI":"10.1016\/j.nucmedbio.2024.108971","volume":"140\u2013141","author":"STM Wenker","year":"2025","unstructured":"Wenker STM, van Lith SAM, Tamborino G, Konijnenberg MW, Bussink J, Heskamp S. The potential of targeted radionuclide therapy to treat hypoxic tumor cells. Nucl Med Biol. 2025;140\u2013141:108971. https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108971.","journal-title":"Nucl Med Biol"},{"key":"444_CR76","doi-asserted-by":"publisher","first-page":"1737443","DOI":"10.3389\/fnume.2025.1737443","volume":"5","author":"X Wu","year":"2025","unstructured":"Wu X, Wang Y, Li Y, Hu W. Recent clinical advances in fibroblast activation protein targeted radioligand therapy for solid tumors. Front Nucl Med. 2025;5:1737443. https:\/\/doi.org\/10.3389\/fnume.2025.1737443.","journal-title":"Front Nucl Med"},{"key":"444_CR77","doi-asserted-by":"publisher","first-page":"648187","DOI":"10.3389\/fonc.2021.648187","volume":"11","author":"L Xin","year":"2021","unstructured":"Xin L, Gao J, Zheng Z, Chen Y, Lv S, Zhao Z, et al. Fibroblast Activation Protein-alpha as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review. Front Oncol. 2021;11:648187. https:\/\/doi.org\/10.3389\/fonc.2021.648187.","journal-title":"Front Oncol"},{"issue":"1","key":"444_CR78","doi-asserted-by":"publisher","first-page":"21273","DOI":"10.1038\/s41598-020-78087-7","volume":"10","author":"I Yakavets","year":"2020","unstructured":"Yakavets I, Francois A, Benoit A, Merlin J-L, Bezdetnaya L, Vogin G. Advanced co-culture 3D breast cancer model for investigation of fibrosis induced by external stimuli: optimization study. Sci Rep. 2020;10(1):21273. https:\/\/doi.org\/10.1038\/s41598-020-78087-7.","journal-title":"Sci Rep"},{"issue":"7","key":"444_CR79","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55(7):1322\u201332. https:\/\/doi.org\/10.1038\/s12276-023-01013-0.","journal-title":"Exp Mol Med"},{"issue":"6","key":"444_CR80","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/cyto.a.22434","volume":"85","author":"K Yumoto","year":"2014","unstructured":"Yumoto K, Berry JE, Taichman RS, Shiozawa Y. A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD. Cytometry A. 2014;85(6):548\u201355. https:\/\/doi.org\/10.1002\/cyto.a.22434.","journal-title":"Cytometry A"},{"key":"444_CR81","doi-asserted-by":"publisher","first-page":"965660","DOI":"10.3389\/fonc.2022.965660","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Dong Y, Wu B, Li Y, Liu Z, Liu Z, et al. Irradiation enhances the malignancy-promoting behaviors of cancer-associated fibroblasts. Front Oncol. 2022;12:965660. https:\/\/doi.org\/10.3389\/fonc.2022.965660.","journal-title":"Front Oncol"},{"issue":"1","key":"444_CR82","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","volume":"19","author":"JY Zhang","year":"2021","unstructured":"Zhang JY, Zhu WW, Wang MY, Zhai RD, Wang Q, Shen WL, et al. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness. J Transl Med. 2021;19(1):513. https:\/\/doi.org\/10.1186\/s12967-021-03181-x.","journal-title":"J Transl Med"},{"issue":"supplement 1","key":"444_CR83","first-page":"251863","volume":"66","author":"L Zhou","year":"2025","unstructured":"Zhou L, Fu W, Ma X, Cagle B, Paranjape N, Dai Z, et al. Preclinical evaluation and first-in-human case of [68Ga]Ga-PSV377, a novel cyclic radiopeptide targeting fibroblast activation protein, for positron emission tomography (PET) imaging of multiple cancers. J Nucl Med. 2025;66(supplement 1):251863.","journal-title":"J Nucl Med"},{"issue":"1","key":"444_CR84","doi-asserted-by":"publisher","first-page":"1950953","DOI":"10.1080\/2162402X.2021.1950953","volume":"10","author":"L Ziani","year":"2021","unstructured":"Ziani L, Buart S, Chouaib S, Thiery J. Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity. Oncoimmunology. 2021;10(1):1950953. https:\/\/doi.org\/10.1080\/2162402X.2021.1950953.","journal-title":"Oncoimmunology"},{"issue":"2","key":"444_CR85","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2967\/jnumed.123.266774","volume":"65","author":"R Zimmermann","year":"2024","unstructured":"Zimmermann R. Is 212Pb Really Happening? The Post-177Lu\/225Ac Blockbuster? J Nucl Med. 2024;65(2):176\u20137. https:\/\/doi.org\/10.2967\/jnumed.123.266774.","journal-title":"J Nucl Med"},{"issue":"6","key":"444_CR86","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.pathol.2023.05.003","volume":"55","author":"M Zubal","year":"2023","unstructured":"Zubal M, Vymolova B, Matrasova I, Vymola P, Veprkova J, Syrucek M, et al. Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours. Pathology. 2023;55(6):806\u201317. https:\/\/doi.org\/10.1016\/j.pathol.2023.05.003.","journal-title":"Pathology"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-026-00444-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-026-00444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:20Z","timestamp":1780617620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41181-026-00444-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1186\/s41181-026-00444-0","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}